Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border

Germana Bancone, Cindy S Chu, Raweewan Somsakchaicharoen, Nongnud Chowwiwat, Daniel M Parker, Prakaykaew Charunwatthana, Nicholas J White, François H Nosten, Germana Bancone, Cindy S Chu, Raweewan Somsakchaicharoen, Nongnud Chowwiwat, Daniel M Parker, Prakaykaew Charunwatthana, Nicholas J White, François H Nosten

Abstract

Mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in red blood cells with increased susceptibility to oxidative damage. Significant haemolysis can be caused by primaquine and other 8-aminoquinoline antimalarials used for the radical treatment of Plasmodium vivax malaria. The distribution and phenotypes of mutations causing G6PD deficiency in the male population of migrants and refugees in a malaria endemic region on the Thailand-Myanmar border were characterized. Blood samples for G6PD fluorescent spot test (FST), G6PD genotyping, and malaria testing were taken from 504 unrelated males of Karen and Burman ethnicities presenting to the outpatient clinics. The overall frequency of G6PD deficiency by the FST was 13.7%. Among the deficient subjects, almost 90% had the Mahidol variant (487G>A) genotype. The remaining subjects had Chinese-4 (392G>T), Viangchan (871G>A), Açores (595A>G), Seattle (844G>C) and Mediterranean (563C>T) variants. Quantification of G6PD activity was performed using a modification of the standard spectrophotometric assay on a subset of 24 samples with Mahidol, Viangchan, Seattle and Chinese-4 mutations; all samples showed a residual enzymatic activity below 10% of normal and were diagnosed correctly by the FST. Further studies are needed to characterise the haemolytic risk of using 8-aminoquinolines in patients with these genotypes.

Conflict of interest statement

Competing Interests: The authors confirm that Nicholas J. White and Francois H. Nosten are PLOS ONE Editorial Board members. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.

Figures

Figure 1. Geographic distribution of G6PD deficient…
Figure 1. Geographic distribution of G6PD deficient variants detected in five SMRU clinics along the Thailand-Myanmar border.
The map indicates the geographic location of the five SMRU clinics where G6PD phenotypes and genotypes were investigated. The white and grey pie charts indicate the proportion of samples taken in each clinic that were either G6PD normal (white) or G6PD deficient (grey). The second-layer pie charts indicate the genetic variants causing phenotypic deficiency at the corresponding site. In two clinics, MLA and MKT, only Mahidol variant was found.

References

    1. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, et al. (2012) G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 9:e1001339.
    1. Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371:64–74.
    1. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, et al. (1977) International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol 35:331–340.
    1. Beutler E, Mitchell M (1968) Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood 32:816–818.
    1. Kim S, Nguon C, Guillard B, Duong S, Chy S, et al. (2011) Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One 6:e28357.
    1. Iwai K, Hirono A, Matsuoka H, Kawamoto F, Horie T, et al. (2001) Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia. Hum Genet 108:445–449.
    1. Matsuoka H, Nguon C, Kanbe T, Jalloh A, Sato H, et al. (2005) Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population. J Hum Genet 50:468–472.
    1. Matsuoka H, Thuan DT, van Thien H, Kanbe T, Jalloh A, et al. (2007) Seven different glucose-6-phosphate dehydrogenase variants including a new variant distributed in Lam Dong Province in southern Vietnam. Acta Med Okayama 61:213–219.
    1. Hue NT, Charlieu JP, Chau TT, Day N, Farrar JJ, et al. (2009) Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population. Malar J 8:152.
    1. Nuchprayoon I, Sanpavat S, Nuchprayoon S (2002) Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population. Hum Mutat 19:185.
    1. Laosombat V, Sattayasevana B, Janejindamai W, Viprakasit V, Shirakawa T, et al. (2005) Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in the south of Thailand and identification of a novel variant (G6PD Songklanagarind). Blood Cells Mol Dis 34:191–196.
    1. Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, et al. (2004) Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>A) is the most common variant in the Myanmar population. J Hum Genet 49:544–547.
    1. Nuchprayoon I, Louicharoen C, Charoenvej W (2008) Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar. J Hum Genet 53:48–54.
    1. Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, et al. (2011) Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J 10:368.
    1. Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, et al. (2013) Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med 10:e1001398.
    1. Huang CS, Hung KL, Huang MJ, Li YC, Liu TH, et al. (1996) Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am J Hematol 51:19–25.
    1. Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, et al. (2009) Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Malar J 8:115.
    1. Chesher D (2008) Evaluating assay precision. Clin Biochem Rev 29 Suppl 1S23–26.
    1. Sanders S, Smith DP, Thomas GA, Williams ED (1997) A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency. Mutat Res 374:79–87.
    1. Panich V, Sungnate T, Wasi P, Na-Nakorn S (1972) G-6-PD Mahidol. The most common glucose-6-phosphate dehydrogenase variant in Thailand. J Med Assoc Thai 55:576–585.
    1. Vulliamy TJ, Wanachiwanawin W, Mason PJ, Luzzatto L (1989) G6PD mahidol, a common deficient variant in South East Asia is caused by a (163)glycine–serine mutation. Nucleic Acids Res 17:5868.
    1. Huang Y, Choi MY, Au SW, Au DM, Lam VM, et al. (2008) Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD(Plymouth) and G6PD(Mahidol): Evidence for defective protein folding as the basis of disease. Mol Genet Metab 93:44–53.
    1. Luzzatto L, Poggi V (2009) Glucose-6-Phosphate Dehydrogenase Deficiency. Nathan and Oskis Hematology of Infancy and Childhood. 7th ed: Saunders.
    1. Manco L, Goncalves P, Antunes P, Maduro F, Abade A, et al. (2007) Mutations and haplotype diversity in 70 Portuguese G6PD-deficient individuals: an overview on the origin and evolution of mutated alleles. Haematologica 92:1713–1714.
    1. Cappellini MD, Martinez di Montemuros F, Dotti C, Tavazzi D, Fiorelli G (1995) Molecular characterisation of the glucose-6-phosphate dehydrogenase (G6PD) Ferrara II variant. Hum Genet 95:440–442.
    1. Cabrera VM, Gonzalez P, Salo WL (1996) Human enzyme polymorphism in the Canary Islands. VII. G6PD Seattle in Canarians and North African Berbers. Hum Hered 46:197–200.
    1. Menounos P, Zervas C, Garinis G, Doukas C, Kolokithopoulos D, et al. (2000) Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population. Hum Hered 50:237–241.
    1. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, et al. (2013) Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 12:418.
    1. Salvidio E, Pannacciulli I, Tizianello A, Gaetani G, Paravidino G (1969) Glucose-6-phosphate dehydrogenase deficiency in Italy. A study of the distribution and severity of the enzymatic defect. Acta Haematol 41:331–340.
    1. Algur N, Avraham I, Hammerman C, Kaplan M (2012) Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype. J Pediatr 161:197–200.
    1. Jamornthanyawat N, Awab GR, Tanomsing N, Pukrittayakamee S, Yamin F, et al. (2014) A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan. PLoS One 9:e88605.
    1. Beutler E, Kuhl W (1990) The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet 47:1008–1012.
    1. De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, et al. (2006) The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal. Haematologica 91:262–263.
    1. Jalloh A, Jalloh M, Gamanga I, Baion D, Sahr F, et al. (2008) G6PD deficiency assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A. J Hum Genet 53:675–679.
    1. Yan T, Cai R, Mo O, Zhu D, Ouyang H, et al. (2006) Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations. Haematologica 91:1321–1328.
    1. Clark TG, Fry AE, Auburn S, Campino S, Diakite M, et al. (2009) Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet 17:1080–1085.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere